It seems we can’t find what you’re looking for. Perhaps searching can help.
1865 - 2015
William Osler Health System – Phase Ib/II Trial of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (mCRPC) (KEYNOTE-365) (*Cohort D only)